Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.0850
+0.0020 (2.41%)
Jul 31, 2026, 4:10 PM AEST
Imugene Market Cap
Imugene has a market cap or net worth of 35.35 million as of July 31, 2026. Its market cap has decreased by -56.24% in one year.
Market Cap
35.35M
Enterprise Value
26.19M
Revenue
3.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 35.35M, an increase of 379.02%. That is a compound annual growth rate of 6.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 35.35M | -69.46% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 57.11M |
| Radiopharm Theranostics | 55.00M |
| Nexsen | 54.05M |
| Botanix Pharmaceuticals | 51.95M |
| Neurizon Therapeutics | 44.78M |
| Noxopharm | 30.72M |
| Patrys | 26.66M |
| Proteomics International Laboratories | 24.78M |